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Background: Total (i.e. free + sulfated) metanephrines in plasma is a biomarker for the diagnosis of pheochro-
mocytoma/paraganglioma. Sulfated metanephrines must be completely deconjugated by perchloric acid hydro-
lysis or sulfatase treatment prior to analytical measurement to enable quantiﬁcation by current techniques. In
this report, we compare the yield and efﬁciency of both methods.
Methods: The deconjugation rate of synthetic sulfated metanephrines (normetanephrine (S-NMN),
metanephrine (S-MN) and methoxytyramine (S-MT)) spiked in charcoal-stripped plasma was determined by
boiling perchloric acid and compared to sulfatase treatment. Total plasma metanephrines (MN, NMN and MT)
were also determined in patient samples by both methods.
Results: The complete deconjugation of sulfated metanephrines is achieved after 30 min incubation with 0.1 M
boiling perchloric acid or upon sulfatase treatment. Ten minutes of acid hydrolysis (gold-standard) leads to a
30% underestimation of metanephrine concentrations. The enzyme hydrolysis is time and amount of sulfatase
dependent. The rate of hydrolysis is analyte-dependent (MTN N NMN N MN), although it must contain at least
0.8 U/ml of sample. The Deming regression curves comparing acid versus enzyme hydrolysis on patient samples
assessed that both methods gave similar unbiased concentrations.
Conclusion: Enzyme and acid treatments are equivalent and efﬁcient for removing sulfate frommetanephrines as
long as the optimal protocol is used for each method. However, the gold standard method for acid hydrolysis at
10 min established more than 20 years ago was not satisfactory regarding the hydrolysis of metanephrines in
plasma.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Biochemical diagnosis of pheochromocytoma relies on themeasure-
ment of metanephrines (normetanephrine (NMN), metanephrine
(MN) and methoxytyramine (MT)) in urine or/and plasma [1–3].
Metanephrines originate from the methoxylation of catecholamines
by catechol-O-methyl-transferase [4]. The monoamine-preferring
sulfotransferase SULT1A3 (E.C. number 2.8.2.1) is responsible for
the sulfate conjugation of metanephrines, giving rise to hydrosoluble
metabolites, considered as end point products eventually eliminated
in urines [5]. In the context of pheochromocytoma diagnostic, urine
total metanephrines (i.e., free + sulfate conjugated) are currently
measured in clinical chemistry laboratories due to high concentra-
tion levels (i.e., about 100–1000 nmol/L). In contrast, plasma total
metanephrines measurement is less frequently available in laboratories
since no commercial kits have been yet developed, necessitating an in-
house analytical validation. The hydrolysis of the sulfate moiety is a41 21 314 78 35.
ann).
ghts reserved.prerequisite to quantifymetanephrines since the analytical methodolo-
gy relies on the redox properties of the free hydroxyl group present on
the benzene ring when measuring by electrochemical detection. Be-
sides, no extraction procedures have yet been reported for sulfated
metanephrines for LC-MS/MS quantiﬁcation. We have previously re-
ported that urine sulfated metanephrines are entirely deconjugated
by a treatment consisting of boiling acid perchloric for 30 min at pH 1.0
[6]. Intriguingly, an early study by Pagliari et al. [7] established that by fol-
lowing the same methodology, the hydrolysis time should not last more
than 10 min to prevent loss of metanephrines. Alternatively, several re-
ports demonstrated that sulfated metanephrines may also be efﬁciently
deconjugated with 0.1 U [8] or 0.5 U of sulfatase for 0.2 ml of plasma
after 30 min incubation at 37 °C [9], or more recently by the same
method after 1 h of incubation with 0.33 U of enzyme [10]. The time-
dependent discrepancy observed between plasma and urine for acid hy-
drolysis of sulfated metanephrines prompted us to evaluate whether
this phenomenon applies to synthetic sulfatedmetanephrines at different
pH and time courses. This was aimed to assess the behavior of synthetic
compounds when used as an internal control for hydrolysis efﬁciency.
In addition, we studied the hydrolysis rate by sulfatase at different en-
zyme concentrations and incubation times to establish optimal hydrolysis
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Fig. 1. Quantiﬁcation of NMN (A), MN (B) and MT (C) in charcoal-stripped plasma
complemented with S-MNs 50 nM sulfated normetanephrine (S-NMN), 20 nM sulfated
metanephrine (S-MN) and 10nMsulfatedmethoxytyramine (S-MT) heated over a boiling
bath (100 °C) for 10, 20, 30, 40 and 60 min (n = 6). Values were expressed in % of MNs
concentrations hydrolyzed. Mean values are indicated by a line for each sextuplicate.
126 M. Glauser et al. / Clinica Chimica Acta 430 (2014) 125–128conditions. We then compared enzyme and acid-treated samples to as-
sess whether both methods gave similar results. Finally, patient samples
were evaluated by bothmethodologies to ensure that totalmetanephrine
concentrations reported inpublications could bepooled for providing rec-
ommendations about normal reference intervals.
2. Materials and Methods
2.1. Reagents, materials and instruments
The chemical protocols used for the synthesis of each sulfate
metanephrines has been previously published [6]. All commercially
available reagents and solvents (Fluka/Aldrich, Buchs, CH and Acros,
Wohlen, CH) were used without further puriﬁcation. Sulfatase from
Aerobacter aerogenes (S1629), normetanephrine and methoxytyramine
were purchased from Sigma-Aldrich (St. Louis, MO, USA), and
metanephrine was supplied by Isosciences (King of Prussia, PA,
USA). Oasis® WCX μElution Plate 30 μm (part no. 186002499) was
obtained from Waters (Milford, MA, USA). Matrix used included
charcoal-stripped human heparinized plasma (Sera Care Life Sci-
ences, Gaithersburg, MD, USA) and plasma samples from patients.
2.2. Validation of hydrolysis conditions
2.2.1. Acid hydrolysis
Charcoal-stripped human heparinized plasma samples (0.2 ml) in
sextuplicate spiked with 50 nM sulfated normetanephrine (S-NMN),
20 nM sulfated metanephrine (S-MN) and 10 nM sulfated methoxy-
tyramine (S-MT) were thoroughly mixed with 0.040 ml of 2 mol/L
perchloric acid, vortexmixed for 10 min on ice to allowprotein precipita-
tion and centrifuged for 10 min at 1800g. The supernatants (0.170 mL)
were recovered in an Eppendorf tube and mixed with 1 ml of
0.02 mol/L perchloric acid. Sulfated metanephrines were hydrolyzed
in a boiling bath (100 °C) for 10, 20, 30, 40 and 60 min, and the hydro-
lysis process was stopped on ice. Free metanephrines (0.1 mL) released
by hydrolysis were brought to pH 6.5 with 0.1 ml of 25 mM sodium
pentaborate containing 1.5 mM EDTA. The samples were then puriﬁed
by solid phase extraction and quantiﬁed by tandemmass spectrometry
[11].
2.2.2. Enzyme hydrolysis
Charcoal-stripped human heparinized plasma samples (0.2 ml) in
sextuplicate spiked with 50 nM S-NMN, 20 nM S-MN and 10 nM S-MT
were mixed with 0, 0.005, 0.01, 0.02, 0.04, 0.08, 0.16 and 0.33 U of sul-
fatase to evaluate the efﬁciency of hydrolysis. The mixture incubation
was performed during 15, 30 and 60 min at 37 °C under gentle shak-
ing. Free metanephrines produced after the enzyme hydrolysis process
were puriﬁed by solid phase extraction and quantiﬁed by tandemmass
spectrometry [11].
2.2.3. Hydrolysis method comparison
Plasma total metanephrine concentrations in plasma samples col-
lected from 62 patients screened for pheochromocytoma were deter-
mined by HPLC with electrochemical detection (Coularray system;
ESA-Dionex, Sunnyvale, CA USA) as routinely performed in our labora-
tory [1]. Results obtained after 10 min and 30 min of acid hydrolysis
were comparedwith those observed after 30 min of enzymehydrolysis.
2.3. Statistical analyses
Results were reported as dot plots after ANOVAs and, when neces-
sary, post hoc Scheffe analyses. Deming regression curves and Bland–
Altman plots were statistically analyzed using the Analyse-it (version
2) add-on package for Microsoft Excel.3. Results and discussion
3.1. Acid hydrolysis
We observed that synthetic sulfated metanephrines are not sponta-
neously hydrolyzed in plasma in acidic conditions as long as they are not
heated at 100 °C (Fig. 1). Only 60% of sulfatedmetanephrines are hydro-
lyzed after 10 min of incubation in boilingwater (Fig. 1). Rising the acid
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Fig. 2. Quantiﬁcation of NMN (A), MN (B) and MT (C) in charcoal-stripped plasma
complemented with S-MNs in presence of 0, 0.005, 0.01, 0.02, 0.04, 0.08, 0.16 and 0.33
U of sulfatase (increasing concentrations from the left to the right column). The mixture
incubation was performed during 15, 30 and 60 min at 37 °C (n = 6). Values were
expressed in % of MNs concentrations hydrolyzed. Mean values are indicated by a line
for each sextuplicate.
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20 min (p b 0.001 for NMN-S and MN-S and p b 0.05 for MT-S, com-
pared to 10 min) with a plateau after 30 min of incubation. Further
hydrolysis up to 60 min incubation did not improve the hydrolysis
yield (yield ranged between 84% and 92%). The data for hydrolysis of
NMN-S and MN-S were normally distributed accordingly to the
Shapiro–Wilk test, whereas MT-S data were not normally distributed
probably reﬂecting a higher variability for the deconjugation of this an-
alyte. These results are in agreement with our previous work on urines
[6], indicating that 30 min is ideal to hydrolyze sulfated metanephrines
and that the nature of the matrix does not affect the hydrolysis rate as
long as the pH is close to 1.0 (pH at 1.2 in our condition). However,
our data are in total discrepancy with the work of Pagliary et al. [7],
who found a maximum concentration of the deconjugation of plasma
S-NMN and S-MN submitted to acid hydrolysis after only 10 min and
gradually lower concentrations of deconjugated metanephrines when
incubation time was 20 and 30 min.
3.2. Enzyme hydrolysis
Enzyme hydrolysis is time- and amount of enzyme-dependent. Ex-
posure to 0.33 U of sulfatase during 15 min at 37 °C resulted in the
100% deconjugation of all sulfated metanephrines (Fig. 2). The yield of
hydrolysis is dependent on the analyte involved with an order of sensi-
tivity for hydrolysis S-MT N N S-NMN N S-MN. The hydrolysis of the
three sulfate metanephrines was not normally distributed due to a sig-
niﬁcant variability for the deconjugation especially at low enzyme con-
centrations. Consequently, 15 min of incubationwith 0.05U of sulfatase
is required to fully remove sulfate fromS-MT (Fig. 2C), 0.16U for S-NMN
(Fig. 2A) and 0.33 U for S-MN (Fig. 2B). Our data indicated that 0.16 U of
enzyme added for 30 min to 0.2 mL plasma is the optimal way to
achieve the full hydrolysis of the sulfate moiety for the three sulfated
metanephrines. Our ﬁnding is intermediate between similar methods
using 0.1 U [8] or 0.5 U of sulfatase for 0.2 ml of plasma during
30 min incubation at 37 °C [9] and certainly spares more time than
the previously proposed 1 h incubation with 0.33 U of enzyme [10].
3.3. Hydrolysis method comparison
Deming regression curves performed in plasma samples collected
from 62 patients conﬁrmed the results observed with synthetic sulfated
metanephrines. We observed an underestimation of about 40% of the
concentrations of S-NMN, S-MN and S-MT in acid-deconjugated
samples for 10 min compared to 30 min (p b 0.0001). In contrast,
the concentrations of total metanephrines in samples treated with
0.16 U sulfatase or acid for 30 min gave similar results, and no
systematic or proportional bias was observed (see Figs. S1A–S1D,
Supplementary data). Bland–Altman plots for the mean difference
between the 62 sample treatments illustrated the differences found in
the Deming regression curves (see Fig. S2A–S2D, Supplementary data).
Our laboratory has established local reference ranges for plasma
total metanephrines measured for the diagnosis of pheochromocytoma
in patients investigated in clinical wards in Switzerland [1]. Since plas-
ma total metanephrines are determined after a deconjugation step in-
cluding a 10-min acid hydrolysis according to the protocol established
by Pagliari et al. [7], we expected a 30%–40% underestimation of real
concentrations of sulfated metanephrines. Our upper reference limits
based on a 97.5 percentile for total metanephrines in hypertensive pa-
tients referred for biochemical measurements because of the presence
of clinical signs suggestive of a pheochromocytoma that was ﬁnally ex-
cluded is 29.92 nmol/L for NMN and 11.26 nmol/L for MN and
9.31 nmol/L for NMN and 5.35 nmol/L for MN in healthy subjects
[1]. These concentrations are similar to those reported by
D'herbonez et al. [12] that used the same protocol that we used to
deconjugate metanephrines. Since adequate sulfatase treatment
should increase these concentrations by 30%–40%, we would expectthat these reference ranges should be reset to 40 nmol/L for NMN
and 15 nmol/l for MN. Pamporaki et al. [9] also reported reference
intervals for total metanephrine measurements based on sulfatase
deconjugation that included amix of healthy volunteers and patients
with primary hypertension and reported similar values at 25.4 nmol/L
for NMN and 9.2 nmol/L for MN (incubation with 0.5 U/0.2 ml plasma
of sulfatase for 30 min), but this population is not similar to ours and is
not truly representative of patients for which a pheochromocytoma is
suspected; instead, the patients for which a pheochromocytoma is ex-
cluded are more representative to establish a cutoff, but unfortunately,
these values are not provided in this article [9]. Eisenhofer et al. [10] pre-
viously reported that incubation of plasma with 0.33 U of sulfatase for
1 hwas enough to produce unconjugatedmetanephrines. They reported
a 97.5 percentile at 31 nmol/l for NMN and 10.3 nmol/L for MN for pa-
tients with primary hypertension. These results were close to our data
published with 10-min acid hydrolysis. A previous study from the
same group, however, established a lower upper reference limit at
16.5 nmol/L for NMN and similar concentrations for MN at 10.9 nmol/L
[8] for hypertensive patients. This discrepancy for only NMN is surprising
since a lower amount of sulfatase (0.1 U/0.2 ml of plasma for 30 min)
128 M. Glauser et al. / Clinica Chimica Acta 430 (2014) 125–128was expected to preferentially affect MN deconjugation since S-MN
proves to be less prone to desulfonation than both S-MT and S-NMN.
All these differences are most likely due to differences in how the
hypertensive control group was deﬁned and taking or not into account
the effect of the combination of anti-hypertensive treatments that may
affect the sympathetic nervous activity and formal evaluation of renal
failure for these patients since sulfated metanephrines are eliminated
through the kidney [10].
In conclusion, we have established the experimental conditions that
allow for a full deconjugation of sulfated metanephrines. Acid or
enzyme (0.16 U/0.2 ml plasma) hydrolysis for 30 min resulted in
similar efﬁciency. Sulfatase treatment costs may be higher than the
acid hydrolysis step, but it is compensated by a signiﬁcant gain in
turnaround time treatment since neither precipitation step of plas-
ma proteins nor pH adjustment prior to SPE are mandatory. The
use of synthetic sulfated metanephrines is also a prerequisite to en-
sure successful MN deconjugation. Finally, this study also highlights
the need to establish interval references for sulfated metanephrines
based on a commondeﬁnition of the referral population to be compared
with patients having a pheochromocytoma (hypertensive patients with
signs suggestive of a pheochromocytoma, hypertensive patients resistant
to anti-hypertensive treatment, patients presenting an incidentaloma,
patients previously having a pheochromocytoma andmonitored for pos-
sible relapse and healthy subjects bearing a mutation for a gene predis-
posing for a pheochromocytoma).
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